The Alliance for Regenerative Medicine (ARM) is an international community of small and large companies, non-profit research institutions, patient organizations, and other sector stakeholders dedicated to realizing the promise of regenerative medicine for patients around the world.

Dr. Ohad Karnieli is a former co-chair of the Science & Technology committee of the ARM.

INACA, Israeli Network for Advanced Cell Applicationwas established as part of the effort to bring different players in the field of Advanced Cell Applications to mutual discussion and collaboration, having on board participants from academy, industry-based companies, hospitals, service providers and regulatory bodies. INACA aims to advance this field in Israel and to expose it to global trends  

ATVIO management are the founders of the INACA foundation and members in its board. 

ISCT mission is to drive the translation of all cellular therapies for the benefit of patients worldwide. 

Dr. Ohad Karnieli is chairing the ISCT process & product development committee and a member in the ISCT commercialization committee, which strives to be the global communication hub between therapeutic societies, regulatory policy makers, institutional stem cell centers and industry for the advancement of clinical investigation in cell therapy and regenerative medicine. 

ISO/TC 276 Biotechnology is working closely with related committees in order to identify standardization needs and gaps and collaborate with other organisations to avoid duplications and overlapping standardization activities.

Dr. Ohad Karnieli is an expert member in the ISO TC276 Bioprocessing committee.